Vivos Therapeutics, Inc. (NASDAQ:VVOS) Q3 2025 Earnings Call Transcript November 19, 2025
Vivos Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.49, expectations were $-0.53.
Operator: Good day, everyone, and welcome to the Vivos Third Quarter 2025 Conference Call. [Operator Instructions] This conference call is being recorded, and a replay of today’s call will be available on the Investor Relations section of Vivos’ website and will remain posted there for the next 30...
